Insider Buy: Iveric Bio
5:05PM ET 6/14/2022 MT NewswiresCalvin W. Roberts, Director, on June 13, 2022, executed a purchase for 25,000 shares in Iveric Bio (ISEE) for $240,500. Following the Form 4 filing with...
Calvin W. Roberts, Director, on June 13, 2022, executed a purchase for 25,000 shares in Iveric Bio (ISEE) for $240,500. Following the Form 4 filing with...
IVERIC Bio (ISEE) shares were up 2.6% in Wednesday midday trading after BofA Securities started coverage of the company with a buy rating and $18 price...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
IVERIC bio (ISEE) has an average rating of outperform and price targets ranging from $12 to $28, according to analysts polled by Capital IQ. (MT Newswires...
Address | 8 Sylvan Way Parsippany, New Jersey 07054 |
Phone | +1.609.474.6755 |
Number of Employees | 35 |
Recent SEC Filing | 06/14/2022![]() |
Chief Executive Officer & Director | Glenn P. Sblendorio |
President | Pravin U. Dugel |
Chief Operating Officer & Senior Vice President | Keith Westby |
Chief Financial Officer, Treasurer & Senior VP | David F. Carroll |
Price Open | $9.64 |
Previous Close | $9.62 |
52 Week Range | $6.30 - 19.35 |
Market Capitalization | $1.1 B |
Shares Outstanding | 116.4 M |
Sector | Health Technology |
Industry | Pharmaceuticals: Major | Next Earnings Announcement | 08/03/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | -$1.13 |
Beta vs. S&P 500 | N/A |
Revenue | $0.00 |
Net Profit Margin | N/A |
Return on Equity | -46.15% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |